Model-guided discovery of MTOR-oriented synergistic drug combinations in colorectal cancer
Colorectal cancer (CRC) exhibits high genetic heterogeneity and frequent resistance to single-agent therapies, highlighting the need for rationally designed drug combinations. We apply a mechanistic modelling framework to prioritise synergistic combinations in 16 CRC cell lines. Simulations of 210 double perturbation...